US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

CEL-SCI Corp

0.2000

-0.0086-4.12%

Volume:1.36M

Turnover:288.98K

Market Cap:16.82M

PE:-0.42

High:0.2213

Open:0.2010

Low:0.1954

Close:0.2086

Loading ...

Overview Company News Filings

CEL-SCI says publication supports strategy to seek early approval for multikine

New Study in the Scientific Journal "Cancer Cell" Supports CEL-SCI’s Strategy to Seek Early Approval for Multikine in Head and Neck Cancer Based on Pre-Surgical Tumor Responses

Experian plc EXPERIAN COMPLETES ACQUISITION OF CLEARSALE

BRIEF-CEL-SCI Reports New Data: Treatment with Multikine Resulted in up to 95% Improvement in Quality of Life for Head and Neck Cancer Patients

BRIEF-CEL-SCI announces closing of $2.5 million offering

CEL-SCI announces pricing of $2.56M common stock offering

CEL-SCI Announces Pricing of $2.5 Million Offering

THOMSON REUTERS

CEL-SCI Announces Pricing of $2.5 Million Offering

CEL-SCI’s Head and Neck Cancer Registration Study Protocol Clears FDA Review—in Talks With Potential Partners Interested in Commercialization of Multikine

THOMSON REUTERS

CEL-SCI’s Head and Neck Cancer Registration Study Protocol Clears FDA Review—in Talks with Potential Partners Interested in Commercialization of Multikine

Journal of the American Medical Association (JAMA) Study Provides Further Evidence that CEL-SCI’s Multikine Can Treat Unmet Need in ~70% of Head and Neck Patients Based on PD-L1 Expression

Brazilian Fintech Meliuz Unveils Bitcoin Reserve Strategy

Quoin Pharmaceuticals Files U.S. and International Patent Applications for Novel Topical Rapamycin Formulations to Treat Rare Disease Indications

GERDAU S.A. - CONSOLIDATED INFORMATION

Press Release: CEL-SCI Reports Fiscal Q1 2025 Financial Results: Multikine Shows Pre-Surgical Tumor Elimination and Regression in Just 3 Weeks

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/CVM/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CVM","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CVM\",,,,,undefined,":{"symbol":"CVM","market":"US","secType":"STK","nameCN":"CEL-SCI Corp","latestPrice":0.2,"timestamp":1744134176298,"preClose":0.2086,"halted":0,"volume":1364556,"delay":0,"floatShares":82317300,"shares":84124041,"eps":-0.479643,"marketStatus":"Trading","change":-0.0086,"latestTime":"04-08 13:42:57 EDT","open":0.201,"high":0.2213,"low":0.1954,"amount":288979.65198804,"amplitude":0.124161,"askPrice":0.2035,"askSize":100,"bidPrice":0.2,"bidSize":400,"shortable":0,"etf":0,"ttmEps":-0.479643,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Market Trading","tradingStatus":3,"beginTime":1744142400000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":433828800000,"exchange":"AMEX","adjPreClose":0.2086,"preHourTrading":{"tag":"盘前","latestPrice":0.2001,"preClose":0.2086,"latestTime":"08:43 EDT","volume":2128,"amount":423.95482192,"timestamp":1744116188116},"postHourTrading":{"tag":"盘后","latestPrice":0.2004,"preClose":0.2086,"latestTime":"19:33 EDT","volume":2843,"amount":590.621664,"timestamp":1744068802919},"volumeRatio":1.660136,"impliedVol":1.2181,"impliedVolPercentile":0.4661},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CVM\",,,,,undefined,":{"symbol":"CVM","floatShares":82317300,"roa":"-61.48%","roe":"-233.26%","lyrEps":-0.510314,"volumeRatio":1.660136,"shares":84124041,"dividePrice":0,"high":0.2213,"amplitude":0.124161,"preClose":0.2086,"low":0.1954,"week52Low":0.1814,"pbRate":"1.49","week52High":2.39,"institutionHeld":0.1743,"latestPrice":0.2,"committee":0.6,"eps":-0.479643,"divideRate":0,"volume":1364556,"delay":0,"ttmEps":-0.479643,"open":0.201,"prevYearClose":0.3999,"prevWeekClose":0.2161,"prevMonthClose":0.2304,"prevQuarterClose":0.2304,"fiveDayClose":0.2195,"twentyDayClose":0.3254,"sixtyDayClose":0.4252},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CVM\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2525813497","title":"CEL-SCI says publication supports strategy to seek early approval for multikine","url":"https://stock-news.laohu8.com/highlight/detail?id=2525813497","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525813497?lang=en_us&edition=fundamental","pubTime":"2025-04-08 21:55","pubTimestamp":1744120525,"startTime":"0","endTime":"0","summary":"CEL-SCI (CVM) announced that a study titled “Distinct CD8+ T cell dynamics associate with response to neoadjuvant cancer immunotherapies” by Li Hou...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cel-sci-says-publication-supports-strategy-to-seek-early-approval-for-multikine?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cel-sci-says-publication-supports-strategy-to-seek-early-approval-for-multikine?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","CVM"],"gpt_icon":0},{"id":"2525813225","title":"New Study in the Scientific Journal \"Cancer Cell\" Supports CEL-SCI’s Strategy to Seek Early Approval for Multikine in Head and Neck Cancer Based on Pre-Surgical Tumor Responses","url":"https://stock-news.laohu8.com/highlight/detail?id=2525813225","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525813225?lang=en_us&edition=fundamental","pubTime":"2025-04-08 21:51","pubTimestamp":1744120260,"startTime":"0","endTime":"0","summary":"Head and neck cancer patients treated with Multikine who had complete or partial tumor responses before surgery had improvements in overall survival, suggesting pre-surgical tumor response is a strong indicator of efficacy and leads to improved overall survival. A third-party head and neck cancer study published in \"Cancer Cell\" confirms the observation that pre-surgical tumor responses in head and neck cancer leads to improved survival. As a neoadjuvant therapy, Multikine is given to patients right after diagnosis, prior to surgery. In the Phase 3 study, pre-surgery objective early tumor response to treatment with Multikine was confirmed by pathology at surgery. There were 45 objective early responders, of which 5 were complete pathological responders, whose t","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/study-scientific-journal-cancer-cell-135100894.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4023","BK4600","BK4588","BK4596","CVM","STRK","BK4585","BK4516","BK4139","BK4595"],"gpt_icon":1},{"id":"2524482613","title":"Experian plc EXPERIAN COMPLETES ACQUISITION OF CLEARSALE","url":"https://stock-news.laohu8.com/highlight/detail?id=2524482613","media":"Dow Jones","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524482613?lang=en_us&edition=fundamental","pubTime":"2025-04-02 14:00","pubTimestamp":1743573600,"startTime":"0","endTime":"0","summary":"2 April 2025 - Further to our announcement on 4 October 2024, we are delighted to announce that all conditions related to the acquisition of ClearSale S.A. , the leading digital fraud prevention provider in Brazil have been satisfied and the transaction has completed .This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Author","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CVM","EXPGY","BK4139","BK4123"],"gpt_icon":0},{"id":"2521729361","title":"BRIEF-CEL-SCI Reports New Data: Treatment with Multikine Resulted in up to 95% Improvement in Quality of Life for Head and Neck Cancer Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2521729361","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521729361?lang=en_us&edition=fundamental","pubTime":"2025-03-24 21:09","pubTimestamp":1742821773,"startTime":"0","endTime":"0","summary":"BRIEF-CEL-SCI Reports New Data: Treatment with Multikine Resulted in up to 95% Improvement in Quality of Life for Head and Neck Cancer PatientsMarch 24 (Reuters) - CEL-SCI Corp CVM.A:CEL-SCI REPORTS N","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250324:nTUA7KTRLR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CVM","BK4139"],"gpt_icon":0},{"id":"2520958412","title":"BRIEF-CEL-SCI announces closing of $2.5 million offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2520958412","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520958412?lang=en_us&edition=fundamental","pubTime":"2025-03-19 05:23","pubTimestamp":1742332991,"startTime":"0","endTime":"0","summary":"BRIEF-CEL-SCI announces closing of $2.5 million offeringMarch 18 (Reuters) - CEL-SCI Corp CVM.A:CEL-SCI ANNOUNCES CLOSING OF $2.5 MILLION OFFERINGSource text: ID:nBwBq9mXaFurther company coverage: CVM.A ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250318:nTUA96D8MM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CVM"],"gpt_icon":0},{"id":"2520507131","title":"CEL-SCI announces pricing of $2.56M common stock offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2520507131","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520507131?lang=en_us&edition=fundamental","pubTime":"2025-03-18 03:35","pubTimestamp":1742240128,"startTime":"0","endTime":"0","summary":"CEL-SCI (CVM) Corporation announced the pricing of a best-efforts offering of 16M shares of its common stock. Total gross proceeds from the offerin...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cel-sci-announces-pricing-of-2-56m-common-stock-offering?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cel-sci-announces-pricing-of-2-56m-common-stock-offering?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CVM","BK4139"],"gpt_icon":0},{"id":"2520250269","title":"CEL-SCI Announces Pricing of $2.5 Million Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2520250269","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520250269?lang=en_us&edition=fundamental","pubTime":"2025-03-18 03:24","pubTimestamp":1742239442,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250317:nTUA8KZY4P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CVM","BK4139"],"gpt_icon":0},{"id":"2520507822","title":"CEL-SCI Announces Pricing of $2.5 Million Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2520507822","media":"Business Wire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520507822?lang=en_us&edition=fundamental","pubTime":"2025-03-18 03:24","pubTimestamp":1742239440,"startTime":"0","endTime":"0","summary":"VIENNA, Va., March 17, 2025----CEL-SCI Corporation  , a Phase 3 cancer immunotherapy company, today announced the pricing of a best-efforts offering of 16,000,000 shares of its common stock . Total gross proceeds from the offering, before deducting the placement agent’s fees and other offering expenses, are expected to be approximately $2,560,000. The offering is expected to close on March 18, 2025, subject to satisfaction of customary closing conditions.The Company intends to use the net proceeds from the offering to fund the continued development of Multikine, general corporate purposes, and working capital.Multikine , given right after diagnosis and before surgery, has been dosed in over 740 patients and received Orphan Drug designation from the FDA for neoadjuvant therapy in patients with squamous cell carcinoma  of the head and neck. Based on the data from the completed randomized controlled Phase 3 study, the FDA concurred with CEL-SCI’s target patient selection criteria and gave","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cel-sci-announces-pricing-2-192400115.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CVM","BK4139"],"gpt_icon":0},{"id":"2520540898","title":"CEL-SCI’s Head and Neck Cancer Registration Study Protocol Clears FDA Review—in Talks With Potential Partners Interested in Commercialization of Multikine","url":"https://stock-news.laohu8.com/highlight/detail?id=2520540898","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520540898?lang=en_us&edition=fundamental","pubTime":"2025-03-17 20:03","pubTimestamp":1742213001,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250317:nFWN3Q010E:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","CVM"],"gpt_icon":0},{"id":"2520528101","title":"CEL-SCI’s Head and Neck Cancer Registration Study Protocol Clears FDA Review—in Talks with Potential Partners Interested in Commercialization of Multikine","url":"https://stock-news.laohu8.com/highlight/detail?id=2520528101","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520528101?lang=en_us&edition=fundamental","pubTime":"2025-03-17 20:00","pubTimestamp":1742212800,"startTime":"0","endTime":"0","summary":"Growing body of data on PD-L1 as a cancer biomarker spurs interest. Working towards partnership for non-dilutive funding of the final confirmatory head and neck cancer Registration Study. CEL-SCI completed a randomized controlled Phase 3 study conducted in 928 locally advanced, resectable head and neck cancer stage 3 and 4a patients in 23 countries on 3 continents. The Phase 3 study demonstrated strong statistical results and improved survival with Multikine neoadjuvant treatment over control. The 5-year survival rate of the target patient population that will be treated in the confirmatory Registration Study increased to 73% when patients were treated with Multikine before standard of care vs 45% for control patients who received only the standard of care treatments. The survival advantage over control was accentuated in patients who had low to zero expression of PD-L1 on their tumors and had lower disease burden by having N0 (no nodal inv","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cel-sci-head-neck-cancer-120000661.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4585","BK4139","BK4528","BK4023","SAP","BK4613","BK4588","CVM"],"gpt_icon":0},{"id":"2519804117","title":"Journal of the American Medical Association (JAMA) Study Provides Further Evidence that CEL-SCI’s Multikine Can Treat Unmet Need in ~70% of Head and Neck Patients Based on PD-L1 Expression","url":"https://stock-news.laohu8.com/highlight/detail?id=2519804117","media":"Business Wire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519804117?lang=en_us&edition=fundamental","pubTime":"2025-03-14 20:30","pubTimestamp":1741955400,"startTime":"0","endTime":"0","summary":"The DEPEND study demonstrates that checkpoint inhibitor nivolumab  works best with high levels of PD-L1 biomarker, but does not work well with low levels of PD-L1. Multikine aims to address a major treatment gap for head and neck cancer patients where about 70% have low PD-L1 expression, in its upcoming confirmatory Registration Trial. \"With these latest findings published in JAMA, industry is taking notice. We believe there is growing interest in Multikine as an advanced clinical stage asset that can prolong life for about 70% of head and neck cancer patients whose tumors have low PD-L1 expression,\" stated CEL-SCI’s CEO Geert Kersten.The DEPEND Phase 2 data also confirm the independent findings reviewed by the FDA’s recent Oncologic Advisory Committee meeting  on the use of checkpoint inhibitors including blockbuster drugs nivolumab and pembrolizumab, which appear to not work well in patients with low PD-L1 expression. To CEL-SCI’s knowledge, Multikine is the only oncology drug with s","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/journal-american-medical-association-jama-123000995.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["PD","AFG","LU1169589451.USD","BK4117","BK4139","BK4023","BK4107","CVM","LU1169590202.USD"],"gpt_icon":0},{"id":"2517195476","title":"Brazilian Fintech Meliuz Unveils Bitcoin Reserve Strategy","url":"https://stock-news.laohu8.com/highlight/detail?id=2517195476","media":"CoinMarketCap","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517195476?lang=en_us&edition=fundamental","pubTime":"2025-03-07 01:49","pubTimestamp":1741283392,"startTime":"0","endTime":"0","summary":"Meliuz, a Brazilian Fintech Company, has made a notable shift in diversifying its investments to feature Bitcoin. In a significant decision, Meliuz gave the nod to a new treasury strategy that would allow the company to set aside resources for Bitcoin  acquisition.According to the report, Meliuz has decided to seek long-term returns via Bitcoin. Hence, it will allow up to 10% of its cash to be invested in Bitcoin. Already, the company has made a significant purchase of 45.72 BTC for $4.1 million.Brazilian fintech unicorn Meliuz has adopted a Bitcoin treasury strategy, reportedly buying millions in BTC to maximize long-term shareholder value.#Bitcoin #Crypto #Meliuz #Brazilian. The initial 10% commitment from Meliuz could be increased to a higher percentage in the future. Notably, Meliuz’s board has called for a detailed analysis of this newly adopted approach and its profitability for the fintech firm.Given Brazil’s crypto-friendly atmosphere, there are speculations of possible digital","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://coinmarketcap.com/community/articles/67c9e041325a5f5d96f1dfa4/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"coinmarketcap_highlight","symbols":["BK4600","BK4023","BTC.USD.HKCC","BK4594","BTC.USD.CC","ETH.USD.CC","FTVI","BK4139","TON.USD.CC","APT.USD.CC","APT.USD.HKCC","BK4595","BK4601","CVM","BK4585","IBIT","MSTU","BTC","ETH.USD.HKCC","BK4596","TON.USD.HKCC","STRK","BK4516","BK4588","MSTR"],"gpt_icon":1},{"id":"2516673956","title":"Quoin Pharmaceuticals Files U.S. and International Patent Applications for Novel Topical Rapamycin Formulations to Treat Rare Disease Indications","url":"https://stock-news.laohu8.com/highlight/detail?id=2516673956","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516673956?lang=en_us&edition=fundamental","pubTime":"2025-03-04 20:30","pubTimestamp":1741091400,"startTime":"0","endTime":"0","summary":"Target Indications Include Microcystic Lymphatic Malformations, Venous Malformations and AngiofibromasProprietary Invisicare Delivery Technology Designed to Optimize Local Skin Penetration Company Pla","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/04/3036382/0/en/Quoin-Pharmaceuticals-Files-U-S-and-International-Patent-Applications-for-Novel-Topical-Rapamycin-Formulations-to-Treat-Rare-Disease-Indications.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","QNRX","CVM"],"gpt_icon":0},{"id":"2512345455","title":"GERDAU S.A. - CONSOLIDATED INFORMATION","url":"https://stock-news.laohu8.com/highlight/detail?id=2512345455","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512345455?lang=en_us&edition=fundamental","pubTime":"2025-02-20 06:53","pubTimestamp":1740005580,"startTime":"0","endTime":"0","summary":"SO PAULO, Feb. 19, 2025 /PRNewswire/ --4Q24 Highlights. Adjusted EBITDA of R$ 2.4 billion in the fourth quarter, up 17.2% from 4Q23.Investments amounted to R$2.4 billion in 4Q24, totaling R$6.2 billion for 2024. For 2025, we estimate an investment of R$6 billion in projects allocated to maintenance and competitiveness.Dividend distribution in the amount of R$ 0.10 per share, equivalent to R$ 203.4 million, to be paid based on 4Q24 results. In 2024, Gerdau S.A.  returned R$2.9 billion through dividends and the buyback program, achieving a return of 65.9% for shareholders.The Company concluded the 2024 share buyback program and approved a new buyback program for up to 64.5 million shares of Gerdau S.A., with a 12-month term.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/gerdau-consolidated-information-225300924.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/gerdau-consolidated-information-225300924.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0532187761.SGD","BK4134","BK4115","CVM","BK4006","BK4139","GGB","IE00B1B80R65.USD","LU0210535034.USD","CNSL","III"],"gpt_icon":0},{"id":"2512157767","title":"Press Release: CEL-SCI Reports Fiscal Q1 2025 Financial Results: Multikine Shows Pre-Surgical Tumor Elimination and Regression in Just 3 Weeks","url":"https://stock-news.laohu8.com/highlight/detail?id=2512157767","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512157767?lang=en_us&edition=fundamental","pubTime":"2025-02-18 21:30","pubTimestamp":1739885400,"startTime":"0","endTime":"0","summary":"CEL-SCI Reports Fiscal Q1 2025 Financial Results: Multikine Shows Pre-Surgical Tumor Elimination and Regression in Just 3 Weeks. CEL-SCI Corporation  today reported financial results for three months ended December 31, 2024, as well as key recent clinical and corporate developments.\"CEL-SCI is very uniquely positioned at this moment as an immuno-oncology company with a vast amount of data from the largest Phase 3 head and neck cancer study ever performed, with statistically significant evidence that our drug can successfully fight cancer and extend lives in head and neck cancer,\" stated CEL-SCI CEO, Geert Kersten. \"We hope to deliver a new standard of care to patients while substantially transforming our company's valuation to reflect what we believe to be the intrinsic value of our cancer drug. The statistical analysis shows that our very soon to be initiated small confirmatory Registration Study has a very high chance of success and we will have indications of efficacy as early as 20","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4528","CVM","BK4139","CEL","BK4023","SAP","BK4585","BK4588"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":58,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CVM\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-02-14","symbol":"CVM","fiscalQuarterEnding":"2024/12","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1739509200000,"reportTimeType":"post","actualEps":-0.11},{"market":"US","date":"2025-01-13","symbol":"CVM","fiscalQuarterEnding":"2024/09","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1736744400000,"reportTimeType":"post","actualEps":-0.09},{"date":"2024-08-15","symbol":"CVM","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2024/06","expectedEps":-0.13,"defaultRemindTime":1723708800000,"name":null,"time":"Pre-Market","dateTimestamp":1723694400000,"actualEps":-0.14},{"date":"2024-05-15","symbol":"CVM","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1715803200000,"name":null,"time":"Post Market","dateTimestamp":1715745600000,"actualEps":null},{"date":"2024-02-15","symbol":"CVM","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2023/12","expectedEps":null,"defaultRemindTime":1707987600000,"name":null,"time":"Pre-Market","dateTimestamp":1707973200000,"actualEps":-0.14}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CVM\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CVM\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":2,"updateTime":1741838400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CVM\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CVM","date":"2025-04-07","current":-0.597113,"percent":0.998377,"low":-36.303853,"twenty":-16.210733,"median":-4.10798,"eighty":-2.343901,"high":-0.549587,"avg":-8.346046,"sd":7.71898,"marketCap":16685414},"quantilePoints":[{"date":"2020-04-09","current":-15.722595,"twenty":-7.281743,"median":-2.481261,"eighty":-0.818503,"marketCap":454570139},{"date":"2020-04-17","current":-14.190584,"twenty":-7.253608,"median":-2.479965,"eighty":-0.817762,"marketCap":410276764},{"date":"2020-04-24","current":-18.851535,"twenty":-7.318328,"median":-2.479965,"eighty":-0.817762,"marketCap":545033726},{"date":"2020-05-01","current":-21.240434,"twenty":-7.318328,"median":-2.479965,"eighty":-0.817762,"marketCap":614101360},{"date":"2020-05-08","current":-17.413353,"twenty":-7.318328,"median":-2.479965,"eighty":-0.817762,"marketCap":549078513},{"date":"2020-05-15","current":-18.738152,"twenty":-7.489378,"median":-2.479965,"eighty":-0.817762,"marketCap":590852135},{"date":"2020-05-22","current":-16.697245,"twenty":-7.601141,"median":-2.479965,"eighty":-0.817762,"marketCap":526498177},{"date":"2020-05-29","current":-15.909526,"twenty":-7.659518,"median":-2.479965,"eighty":-0.817762,"marketCap":501659807},{"date":"2020-06-05","current":-16.947883,"twenty":-7.762127,"median":-2.479965,"eighty":-0.817762,"marketCap":534401294},{"date":"2020-06-12","current":-15.420186,"twenty":-7.879311,"median":-2.479965,"eighty":-0.817762,"marketCap":486229910},{"date":"2020-06-19","current":-16.279515,"twenty":-7.985806,"median":-2.479965,"eighty":-0.817762,"marketCap":513326314},{"date":"2020-06-26","current":-18.189136,"twenty":-8.062403,"median":-2.479965,"eighty":-0.817762,"marketCap":573540544},{"date":"2020-07-02","current":-16.529405,"twenty":-8.151538,"median":-2.479965,"eighty":-0.817762,"marketCap":521205853},{"date":"2020-07-10","current":-17.470103,"twenty":-8.186901,"median":-2.479965,"eighty":-0.817762,"marketCap":550867974},{"date":"2020-07-17","current":-17.665573,"twenty":-8.266839,"median":-2.479965,"eighty":-0.817762,"marketCap":557031532},{"date":"2020-07-24","current":-16.236201,"twenty":-8.314192,"median":-2.479965,"eighty":-0.817762,"marketCap":511960516},{"date":"2020-07-31","current":-15.283286,"twenty":-8.342981,"median":-2.479965,"eighty":-0.817762,"marketCap":481913172},{"date":"2020-08-07","current":-14.892347,"twenty":-8.412596,"median":-2.479965,"eighty":-0.817762,"marketCap":469586056},{"date":"2020-08-14","current":-16.503475,"twenty":-8.470363,"median":-2.479965,"eighty":-0.817762,"marketCap":490912107},{"date":"2020-08-21","current":-16.555414,"twenty":-8.562705,"median":-2.479965,"eighty":-0.817762,"marketCap":492457071},{"date":"2020-08-28","current":-17.503292,"twenty":-8.806363,"median":-2.479965,"eighty":-0.817762,"marketCap":520652652},{"date":"2020-09-04","current":-17.607169,"twenty":-8.984749,"median":-2.479965,"eighty":-0.817762,"marketCap":523742579},{"date":"2020-09-11","current":-17.204646,"twenty":-9.06225,"median":-2.479965,"eighty":-0.817762,"marketCap":511769113},{"date":"2020-09-18","current":-18.619971,"twenty":-9.115153,"median":-2.479965,"eighty":-0.817762,"marketCap":553869364},{"date":"2020-09-25","current":-16.51646,"twenty":-9.194573,"median":-2.479965,"eighty":-0.817762,"marketCap":491298348},{"date":"2020-10-02","current":-17.620154,"twenty":-9.28401,"median":-2.479965,"eighty":-0.817762,"marketCap":524128819},{"date":"2020-10-09","current":-19.308157,"twenty":-9.372965,"median":-2.479965,"eighty":-0.817762,"marketCap":574340129},{"date":"2020-10-16","current":-20.80139,"twenty":-9.416922,"median":-2.479965,"eighty":-0.817762,"marketCap":618757825},{"date":"2020-10-23","current":-17.022861,"twenty":-9.659475,"median":-2.479965,"eighty":-0.817762,"marketCap":506361741},{"date":"2020-10-30","current":-15.665686,"twenty":-9.745942,"median":-2.479965,"eighty":-0.817762,"marketCap":465991240},{"date":"2020-11-06","current":-15.066665,"twenty":-9.920207,"median":-2.479965,"eighty":-0.817762,"marketCap":448172789},{"date":"2020-11-13","current":-16.499106,"twenty":-10.207212,"median":-2.479965,"eighty":-0.817762,"marketCap":490782129},{"date":"2020-11-20","current":-15.900085,"twenty":-10.500982,"median":-2.479965,"eighty":-0.817762,"marketCap":472963678},{"date":"2020-11-27","current":-16.850704,"twenty":-10.692293,"median":-2.479965,"eighty":-0.817762,"marketCap":501240786},{"date":"2020-12-04","current":-15.652664,"twenty":-11.010512,"median":-2.479965,"eighty":-0.817762,"marketCap":465603883},{"date":"2020-12-11","current":-19.339597,"twenty":-11.212214,"median":-2.482557,"eighty":-0.817762,"marketCap":575275353},{"date":"2020-12-18","current":-17.48182,"twenty":-12.418034,"median":-2.492735,"eighty":-0.817762,"marketCap":520013934},{"date":"2020-12-24","current":-17.120957,"twenty":-12.792988,"median":-2.500417,"eighty":-0.817762,"marketCap":509279701},{"date":"2020-12-31","current":-15.310637,"twenty":-13.515253,"median":-2.518522,"eighty":-0.817762,"marketCap":463559822},{"date":"2021-01-08","current":-18.25196,"twenty":-13.798902,"median":-2.526554,"eighty":-0.817762,"marketCap":552614196},{"date":"2021-01-15","current":-18.742981,"twenty":-14.056407,"median":-2.535735,"eighty":-0.817762,"marketCap":567480812},{"date":"2021-01-22","current":-18.716712,"twenty":-14.394355,"median":-2.535735,"eighty":-0.817762,"marketCap":566685464},{"date":"2021-01-29","current":-32.770663,"twenty":-14.574252,"median":-2.535735,"eighty":-0.817762,"marketCap":992196654},{"date":"2021-02-05","current":-30.984367,"twenty":-14.773602,"median":-2.535735,"eighty":-0.817762,"marketCap":938112989},{"date":"2021-02-12","current":-29.127713,"twenty":-14.836217,"median":-2.557047,"eighty":-0.817762,"marketCap":954464496},{"date":"2021-02-19","current":-24.539016,"twenty":-14.892347,"median":-2.570115,"eighty":-0.817762,"marketCap":804100875},{"date":"2021-02-26","current":-21.954009,"twenty":-14.992143,"median":-2.570115,"eighty":-0.817762,"marketCap":719394684},{"date":"2021-03-05","current":-24.019541,"twenty":-15.091995,"median":-2.57578,"eighty":-0.817762,"marketCap":787078578},{"date":"2021-03-12","current":-25.293492,"twenty":-15.193271,"median":-2.602518,"eighty":-0.817762,"marketCap":828823735},{"date":"2021-03-19","current":-21.892166,"twenty":-15.25121,"median":-2.616574,"eighty":-0.817762,"marketCap":717368220},{"date":"2021-03-26","current":-20.333741,"twenty":-15.328113,"median":-2.629256,"eighty":-0.818503,"marketCap":666301330},{"date":"2021-04-01","current":-20.370846,"twenty":-15.523478,"median":-2.642183,"eighty":-0.818503,"marketCap":667517208},{"date":"2021-04-09","current":-19.950319,"twenty":-15.637604,"median":-2.682036,"eighty":-0.817762,"marketCap":653737254},{"date":"2021-04-16","current":-21.607692,"twenty":-15.727789,"median":-2.952382,"eighty":-0.817762,"marketCap":708046486},{"date":"2021-04-23","current":-30.203768,"twenty":-15.842734,"median":-3.11969,"eighty":-0.817762,"marketCap":989724968},{"date":"2021-04-30","current":-29.845083,"twenty":-15.945112,"median":-3.220938,"eighty":-0.817762,"marketCap":977971478},{"date":"2021-05-07","current":-26.456126,"twenty":-16.001259,"median":-3.342026,"eighty":-0.817762,"marketCap":866921256},{"date":"2021-05-14","current":-27.618761,"twenty":-16.12622,"median":-3.420304,"eighty":-0.817762,"marketCap":905018777},{"date":"2021-05-21","current":-24.359361,"twenty":-16.194926,"median":-3.471932,"eighty":-0.817762,"marketCap":850039002},{"date":"2021-05-28","current":-25.215104,"twenty":-16.242394,"median":-3.499441,"eighty":-0.817762,"marketCap":879900815},{"date":"2021-06-04","current":-28.978027,"twenty":-16.27136,"median":-3.562279,"eighty":-0.817762,"marketCap":1011210978},{"date":"2021-06-11","current":-27.068328,"twenty":-16.313109,"median":-3.626813,"eighty":-0.817762,"marketCap":944570533},{"date":"2021-06-18","current":-27.019578,"twenty":-16.463579,"median":-3.656855,"eighty":-0.817762,"marketCap":942869371},{"date":"2021-06-25","current":-30.566127,"twenty":-16.539276,"median":-3.704254,"eighty":-0.817762,"marketCap":1066628950},{"date":"2021-07-02","current":-9.859342,"twenty":-16.554579,"median":-3.81599,"eighty":-0.817762,"marketCap":344049473},{"date":"2021-07-09","current":-10.888143,"twenty":-16.554579,"median":-3.886922,"eighty":-0.817762,"marketCap":379950287},{"date":"2021-07-16","current":-9.712371,"twenty":-16.554579,"median":-3.975297,"eighty":-0.817762,"marketCap":338920785},{"date":"2021-07-23","current":-9.40618,"twenty":-16.554579,"median":-4.078552,"eighty":-0.817762,"marketCap":328236019},{"date":"2021-07-30","current":-9.834847,"twenty":-16.554579,"median":-4.143086,"eighty":-0.817762,"marketCap":343194691},{"date":"2021-08-06","current":-11.231077,"twenty":-16.554579,"median":-4.233433,"eighty":-0.817762,"marketCap":391917226},{"date":"2021-08-13","current":-11.466148,"twenty":-16.554579,"median":-4.310874,"eighty":-0.817762,"marketCap":388544194},{"date":"2021-08-20","current":-12.10104,"twenty":-16.554579,"median":-4.432946,"eighty":-0.817762,"marketCap":410058269},{"date":"2021-08-27","current":-13.700968,"twenty":-16.554579,"median":-4.607581,"eighty":-0.817762,"marketCap":464273738},{"date":"2021-09-03","current":-14.615212,"twenty":-16.554579,"median":-4.744934,"eighty":-0.817762,"marketCap":495254006},{"date":"2021-09-10","current":-14.577119,"twenty":-16.554579,"median":-4.782394,"eighty":-0.817762,"marketCap":493963162},{"date":"2021-09-17","current":-15.440572,"twenty":-16.554579,"median":-4.949865,"eighty":-0.817762,"marketCap":523222304},{"date":"2021-09-24","current":-15.173917,"twenty":-16.554579,"median":-5.094561,"eighty":-0.817762,"marketCap":514186392},{"date":"2021-10-01","current":-14.462838,"twenty":-16.554579,"median":-5.319321,"eighty":-0.817762,"marketCap":490090628},{"date":"2021-10-08","current":-12.862911,"twenty":-16.554579,"median":-5.785203,"eighty":-0.817762,"marketCap":435875159},{"date":"2021-10-15","current":-13.205752,"twenty":-16.554579,"median":-6.107319,"eighty":-0.817762,"marketCap":447492760},{"date":"2021-10-22","current":-14.500932,"twenty":-16.554579,"median":-6.705482,"eighty":-0.817762,"marketCap":491381473},{"date":"2021-10-29","current":-14.221579,"twenty":-16.554579,"median":-7.035014,"eighty":-0.817762,"marketCap":481915280},{"date":"2021-11-05","current":-15.2755,"twenty":-16.554579,"median":-7.331381,"eighty":-0.817762,"marketCap":517628644},{"date":"2021-11-12","current":-15.478665,"twenty":-16.554579,"median":-7.497948,"eighty":-0.817762,"marketCap":524513148},{"date":"2021-11-19","current":-13.942227,"twenty":-16.554579,"median":-7.614194,"eighty":-0.817762,"marketCap":472449087},{"date":"2021-11-26","current":-12.977191,"twenty":-16.554579,"median":-7.668581,"eighty":-0.817762,"marketCap":439747693},{"date":"2021-12-03","current":-10.843954,"twenty":-16.554579,"median":-7.788232,"eighty":-0.827975,"marketCap":367460401},{"date":"2021-12-10","current":-11.237587,"twenty":-16.554579,"median":-7.8854,"eighty":-0.859111,"marketCap":380799127},{"date":"2021-12-17","current":-10.323343,"twenty":-16.554579,"median":-7.988477,"eighty":-0.879153,"marketCap":349818859},{"date":"2021-12-23","current":-9.859358,"twenty":-16.554579,"median":-8.049389,"eighty":-0.891677,"marketCap":361956448},{"date":"2021-12-31","current":-8.363374,"twenty":-16.554579,"median":-8.158065,"eighty":-0.93448,"marketCap":307035935},{"date":"2022-01-07","current":-7.291449,"twenty":-16.554301,"median":-8.158065,"eighty":-0.951103,"marketCap":267683442},{"date":"2022-01-14","current":-7.786183,"twenty":-16.554301,"median":-8.158065,"eighty":-0.96443,"marketCap":285846131},{"date":"2022-01-21","current":-6.643582,"twenty":-16.554301,"median":-8.158065,"eighty":-0.990095,"marketCap":243898968},{"date":"2022-01-28","current":-6.737817,"twenty":-16.554301,"median":-8.158065,"eighty":-1.013469,"marketCap":247358528},{"date":"2022-02-04","current":-6.584685,"twenty":-16.554301,"median":-8.158065,"eighty":-1.027849,"marketCap":241736743},{"date":"2022-02-11","current":-6.501997,"twenty":-16.554301,"median":-8.158065,"eighty":-1.040287,"marketCap":243642404},{"date":"2022-02-18","current":-6.132434,"twenty":-16.554301,"median":-8.158065,"eighty":-1.062721,"marketCap":229794168},{"date":"2022-02-25","current":-6.490448,"twenty":-16.554301,"median":-8.158065,"eighty":-1.085691,"marketCap":243209647},{"date":"2022-03-04","current":-5.728225,"twenty":-16.554301,"median":-8.158065,"eighty":-1.106996,"marketCap":214647660},{"date":"2022-03-11","current":-5.312467,"twenty":-16.554301,"median":-8.158065,"eighty":-1.158225,"marketCap":199068394},{"date":"2022-03-18","current":-5.77442,"twenty":-16.554301,"median":-8.158065,"eighty":-1.189564,"marketCap":216378690},{"date":"2022-03-25","current":-4.619536,"twenty":-16.554301,"median":-8.158065,"eighty":-1.226566,"marketCap":173102952},{"date":"2022-04-01","current":-4.515597,"twenty":-16.554301,"median":-8.158065,"eighty":-1.233418,"marketCap":169208135},{"date":"2022-04-08","current":-4.527145,"twenty":-16.554301,"median":-8.158065,"eighty":-1.247123,"marketCap":169640892},{"date":"2022-04-14","current":-3.811117,"twenty":-16.554301,"median":-8.158065,"eighty":-1.26768,"marketCap":142809935},{"date":"2022-04-22","current":-3.314517,"twenty":-16.554301,"median":-8.158065,"eighty":-1.280014,"marketCap":124201368},{"date":"2022-04-29","current":-3.306011,"twenty":-16.554301,"median":-8.158065,"eighty":-1.300358,"marketCap":123882641},{"date":"2022-05-06","current":-3.525642,"twenty":-16.554301,"median":-8.158065,"eighty":-1.396504,"marketCap":132112607},{"date":"2022-05-13","current":-3.408543,"twenty":-16.554301,"median":-8.158065,"eighty":-1.567315,"marketCap":123048702},{"date":"2022-05-20","current":-3.756599,"twenty":-16.554301,"median":-8.158065,"eighty":-1.692999,"marketCap":135613535},{"date":"2022-05-27","current":-4.188668,"twenty":-16.554301,"median":-8.158065,"eighty":-1.773964,"marketCap":151211257},{"date":"2022-06-03","current":-4.464712,"twenty":-16.554301,"median":-8.158065,"eighty":-1.827608,"marketCap":161176469},{"date":"2022-06-10","current":-4.020641,"twenty":-16.554301,"median":-8.158065,"eighty":-1.879456,"marketCap":145145476},{"date":"2022-06-17","current":-4.716752,"twenty":-16.554301,"median":-8.158065,"eighty":-1.922204,"marketCap":170275141},{"date":"2022-06-24","current":-5.388859,"twenty":-16.554579,"median":-8.158065,"eighty":-1.986916,"marketCap":194538265},{"date":"2022-07-01","current":-4.920909,"twenty":-16.554579,"median":-8.158065,"eighty":-2.104754,"marketCap":177645226},{"date":"2022-07-08","current":-5.545024,"twenty":-16.554579,"median":-8.158065,"eighty":-2.147391,"marketCap":200175840},{"date":"2022-07-15","current":-4.608851,"twenty":-16.554579,"median":-8.158065,"eighty":-2.267774,"marketCap":166379919},{"date":"2022-07-22","current":-4.584847,"twenty":-16.554579,"median":-8.158065,"eighty":-2.342744,"marketCap":165513357},{"date":"2022-07-29","current":-4.596849,"twenty":-16.554579,"median":-8.158065,"eighty":-2.385632,"marketCap":165946638},{"date":"2022-08-05","current":-5.052933,"twenty":-16.554579,"median":-8.158065,"eighty":-2.441697,"marketCap":182411317},{"date":"2022-08-12","current":-4.922494,"twenty":-16.554579,"median":-8.158065,"eighty":-2.459289,"marketCap":180842316},{"date":"2022-08-19","current":-5.170389,"twenty":-16.554579,"median":-8.158065,"eighty":-2.496095,"marketCap":189949483},{"date":"2022-08-26","current":-4.62738,"twenty":-16.554579,"median":-8.158065,"eighty":-2.52589,"marketCap":170000451},{"date":"2022-09-02","current":-4.532944,"twenty":-16.554579,"median":-8.158065,"eighty":-2.565239,"marketCap":166531054},{"date":"2022-09-09","current":-4.957907,"twenty":-16.554579,"median":-8.158065,"eighty":-2.577527,"marketCap":182143340},{"date":"2022-09-16","current":-4.875276,"twenty":-16.554579,"median":-8.158065,"eighty":-2.615174,"marketCap":179107618},{"date":"2022-09-23","current":-4.131589,"twenty":-16.554579,"median":-8.158065,"eighty":-2.629256,"marketCap":151786117},{"date":"2022-09-30","current":-3.647603,"twenty":-16.554579,"median":-8.158065,"eighty":-2.650331,"marketCap":134005457},{"date":"2022-10-07","current":-3.989935,"twenty":-16.554579,"median":-8.158065,"eighty":-2.709192,"marketCap":146582021},{"date":"2022-10-14","current":-3.730235,"twenty":-16.554579,"median":-8.158065,"eighty":-2.97036,"marketCap":137041179},{"date":"2022-10-21","current":-3.541362,"twenty":-16.554579,"median":-8.158065,"eighty":-3.086022,"marketCap":130102386},{"date":"2022-10-28","current":-4.10798,"twenty":-16.554579,"median":-8.158065,"eighty":-3.173453,"marketCap":150918767},{"date":"2022-11-04","current":-4.084371,"twenty":-16.554579,"median":-8.158065,"eighty":-3.238566,"marketCap":150051418},{"date":"2022-11-11","current":-3.97813,"twenty":-16.554579,"median":-8.158065,"eighty":-3.306011,"marketCap":146148346},{"date":"2022-11-18","current":-3.505949,"twenty":-16.554579,"median":-8.158065,"eighty":-3.349291,"marketCap":128801362},{"date":"2022-11-25","current":-3.564971,"twenty":-16.554579,"median":-8.158065,"eighty":-3.375176,"marketCap":130969735},{"date":"2022-12-02","current":-3.423317,"twenty":-16.554579,"median":-8.158065,"eighty":-3.422112,"marketCap":125765639},{"date":"2022-12-09","current":-2.821285,"twenty":-16.554579,"median":-8.158065,"eighty":-3.422112,"marketCap":103648234},{"date":"2022-12-16","current":-2.455345,"twenty":-16.554579,"median":-8.158065,"eighty":-3.422112,"marketCap":90204320},{"date":"2022-12-23","current":-2.70324,"twenty":-16.554579,"median":-8.158065,"eighty":-3.422112,"marketCap":99311487},{"date":"2022-12-30","current":-2.727829,"twenty":-16.554579,"median":-8.158065,"eighty":-3.422112,"marketCap":102647678},{"date":"2023-01-06","current":-2.890338,"twenty":-16.554579,"median":-8.158065,"eighty":-3.422112,"marketCap":108762858},{"date":"2023-01-13","current":-3.319826,"twenty":-16.554579,"median":-8.158065,"eighty":-3.422112,"marketCap":124924408},{"date":"2023-01-20","current":-3.296611,"twenty":-16.554579,"median":-8.158065,"eighty":-3.423904,"marketCap":124050810},{"date":"2023-01-27","current":-3.180533,"twenty":-16.554579,"median":-8.158065,"eighty":-3.423904,"marketCap":119682824},{"date":"2023-02-03","current":-3.110886,"twenty":-16.554579,"median":-8.158065,"eighty":-3.423904,"marketCap":117062032},{"date":"2023-02-10","current":-3.238572,"twenty":-16.554579,"median":-8.158065,"eighty":-3.423904,"marketCap":121866817},{"date":"2023-02-17","current":-3.60613,"twenty":-16.554579,"median":-8.158065,"eighty":-3.425791,"marketCap":132966149},{"date":"2023-02-24","current":-3.096052,"twenty":-16.554579,"median":-8.158065,"eighty":-3.427633,"marketCap":114158437},{"date":"2023-03-03","current":-3.511232,"twenty":-16.554579,"median":-8.158065,"eighty":-3.434617,"marketCap":129467040},{"date":"2023-03-10","current":-2.799496,"twenty":-16.554579,"median":-8.158065,"eighty":-3.438897,"marketCap":103223721},{"date":"2023-03-17","current":-2.633424,"twenty":-16.554579,"median":-8.158065,"eighty":-3.438897,"marketCap":97100280},{"date":"2023-03-24","current":-2.680873,"twenty":-16.554579,"median":-8.158065,"eighty":-3.438897,"marketCap":98849834},{"date":"2023-03-31","current":-2.752046,"twenty":-16.554301,"median":-8.158065,"eighty":-3.436757,"marketCap":101474166},{"date":"2023-04-06","current":-2.704597,"twenty":-16.554301,"median":-8.158065,"eighty":-3.436757,"marketCap":99724612},{"date":"2023-04-14","current":-2.884201,"twenty":-16.554579,"median":-8.158065,"eighty":-3.438897,"marketCap":106347001},{"date":"2023-04-21","current":-3.109715,"twenty":-16.554579,"median":-8.158065,"eighty":-3.438897,"marketCap":114662198},{"date":"2023-04-28","current":-2.528127,"twenty":-16.554579,"median":-8.158065,"eighty":-3.438897,"marketCap":93217741},{"date":"2023-05-05","current":-2.885438,"twenty":-16.554579,"median":-8.158065,"eighty":-3.438897,"marketCap":106392623},{"date":"2023-05-12","current":-3.28552,"twenty":-16.554579,"median":-8.158065,"eighty":-3.438897,"marketCap":121144541},{"date":"2023-05-19","current":-3.220882,"twenty":-16.554579,"median":-8.158065,"eighty":-3.438897,"marketCap":113992096},{"date":"2023-05-26","current":-2.969054,"twenty":-16.554579,"median":-8.158065,"eighty":-3.438897,"marketCap":105079495},{"date":"2023-06-02","current":-3.04486,"twenty":-16.554579,"median":-8.158065,"eighty":-3.438897,"marketCap":107762376},{"date":"2023-06-09","current":-3.221739,"twenty":-16.554579,"median":-8.158065,"eighty":-3.438897,"marketCap":114022431},{"date":"2023-06-16","current":-3.04486,"twenty":-16.554579,"median":-8.158065,"eighty":-3.438897,"marketCap":107762376},{"date":"2023-06-23","current":-2.842711,"twenty":-16.554858,"median":-8.158065,"eighty":-3.438897,"marketCap":100608027},{"date":"2023-06-30","current":-3.006957,"twenty":-16.555136,"median":-8.158065,"eighty":-3.445225,"marketCap":106420936},{"date":"2023-07-07","current":-3.095397,"twenty":-16.555136,"median":-8.158065,"eighty":-3.445225,"marketCap":109550963},{"date":"2023-07-14","current":-2.95642,"twenty":-16.555136,"median":-8.158065,"eighty":-3.445225,"marketCap":104632348},{"date":"2023-07-21","current":-2.63008,"twenty":-16.555136,"median":-8.158065,"eighty":-3.470535,"marketCap":93082691},{"date":"2023-07-28","current":-2.282963,"twenty":-16.555136,"median":-8.158065,"eighty":-3.470535,"marketCap":80797665},{"date":"2023-08-04","current":-2.096054,"twenty":-16.555136,"median":-8.158065,"eighty":-3.470535,"marketCap":74182652},{"date":"2023-08-11","current":-1.895794,"twenty":-16.555136,"median":-8.158065,"eighty":-3.470535,"marketCap":67095137},{"date":"2023-08-18","current":-1.746139,"twenty":-16.555136,"median":-8.158065,"eighty":-3.470535,"marketCap":59075121},{"date":"2023-08-25","current":-1.899799,"twenty":-16.555136,"median":-8.158065,"eighty":-3.470535,"marketCap":64273731},{"date":"2023-09-01","current":-1.941706,"twenty":-16.555136,"median":-8.158065,"eighty":-3.470535,"marketCap":65691534},{"date":"2023-09-08","current":-1.788046,"twenty":-16.555136,"median":-8.158065,"eighty":-3.438897,"marketCap":60492924},{"date":"2023-09-15","current":-1.732169,"twenty":-16.555136,"median":-8.158065,"eighty":-3.424794,"marketCap":58602520},{"date":"2023-09-22","current":-1.704231,"twenty":-16.555136,"median":-8.158065,"eighty":-3.408904,"marketCap":57657318},{"date":"2023-09-29","current":-1.690262,"twenty":-16.555136,"median":-8.158065,"eighty":-3.359935,"marketCap":57184717},{"date":"2023-10-06","current":-1.522633,"twenty":-16.555136,"median":-8.158065,"eighty":-3.340953,"marketCap":51513505},{"date":"2023-10-13","current":-1.648355,"twenty":-16.555136,"median":-8.158065,"eighty":-3.323464,"marketCap":55766914},{"date":"2023-10-20","current":-1.578509,"twenty":-16.555136,"median":-8.158065,"eighty":-3.306452,"marketCap":53403909},{"date":"2023-10-27","current":-1.88583,"twenty":-16.555414,"median":-8.188189,"eighty":-3.305529,"marketCap":63801130},{"date":"2023-11-03","current":-2.584285,"twenty":-16.555414,"median":-8.188189,"eighty":-3.27978,"marketCap":87431179},{"date":"2023-11-10","current":-3.338617,"twenty":-16.555414,"median":-8.188189,"eighty":-3.268215,"marketCap":112951631},{"date":"2023-11-17","current":-3.115111,"twenty":-16.555414,"median":-8.188189,"eighty":-3.261184,"marketCap":105390016},{"date":"2023-11-24","current":-3.72287,"twenty":-16.555414,"median":-8.188189,"eighty":-3.259721,"marketCap":125951626},{"date":"2023-12-01","current":-3.323991,"twenty":-16.555414,"median":-8.188189,"eighty":-3.259721,"marketCap":112456809},{"date":"2023-12-08","current":-3.841056,"twenty":-16.555414,"median":-8.181747,"eighty":-3.259642,"marketCap":129950090},{"date":"2023-12-15","current":-4.180842,"twenty":-16.555414,"median":-8.181747,"eighty":-3.259642,"marketCap":141445675},{"date":"2023-12-22","current":-4.123134,"twenty":-16.555414,"median":-8.181747,"eighty":-3.267442,"marketCap":133448746},{"date":"2023-12-29","current":-4.385655,"twenty":-16.555414,"median":-8.188189,"eighty":-3.27978,"marketCap":141945483},{"date":"2024-01-05","current":-3.72163,"twenty":-16.555414,"median":-8.194631,"eighty":-3.300075,"marketCap":120453737},{"date":"2024-01-12","current":-3.798842,"twenty":-16.555414,"median":-8.194631,"eighty":-3.310738,"marketCap":122952777},{"date":"2024-01-19","current":-3.690745,"twenty":-16.555414,"median":-8.203542,"eighty":-3.323991,"marketCap":119454121},{"date":"2024-01-26","current":-4.138576,"twenty":-16.555414,"median":-8.194631,"eighty":-3.334233,"marketCap":133948554},{"date":"2024-02-02","current":-4.231231,"twenty":-16.555414,"median":-8.194631,"eighty":-3.34328,"marketCap":136947402},{"date":"2024-02-09","current":-4.401098,"twenty":-16.555414,"median":-8.194631,"eighty":-3.378353,"marketCap":142445291},{"date":"2024-02-16","current":-4.102727,"twenty":-16.555414,"median":-8.194631,"eighty":-3.410709,"marketCap":127390985},{"date":"2024-02-23","current":-3.755038,"twenty":-16.555414,"median":-8.194631,"eighty":-3.422786,"marketCap":116595138},{"date":"2024-03-01","current":-3.615963,"twenty":-16.555414,"median":-8.188189,"eighty":-3.428196,"marketCap":112276800},{"date":"2024-03-08","current":-3.963652,"twenty":-16.555414,"median":-8.188189,"eighty":-3.470535,"marketCap":123072646},{"date":"2024-03-15","current":-3.668116,"twenty":-16.555414,"median":-8.188189,"eighty":-3.470535,"marketCap":113896177},{"date":"2024-03-22","current":-3.285659,"twenty":-16.555414,"median":-8.188189,"eighty":-3.459169,"marketCap":102020746},{"date":"2024-03-28","current":-3.285659,"twenty":-16.555414,"median":-8.188189,"eighty":-3.423904,"marketCap":102020746},{"date":"2024-04-05","current":-3.024892,"twenty":-16.555414,"median":-8.194631,"eighty":-3.397101,"marketCap":93923861},{"date":"2024-04-12","current":-2.885817,"twenty":-16.555414,"median":-8.194631,"eighty":-3.339444,"marketCap":89605523},{"date":"2024-04-19","current":-2.607666,"twenty":-16.555414,"median":-8.194631,"eighty":-3.324821,"marketCap":80968846},{"date":"2024-04-26","current":-2.520743,"twenty":-16.555414,"median":-8.158065,"eighty":-3.320187,"marketCap":78269884},{"date":"2024-05-03","current":-2.572897,"twenty":-16.555414,"median":-8.063626,"eighty":-3.305715,"marketCap":79889261},{"date":"2024-05-10","current":-2.62505,"twenty":-16.555414,"median":-7.973149,"eighty":-3.284927,"marketCap":81508638},{"date":"2024-05-17","current":-2.523034,"twenty":-16.555414,"median":-7.880326,"eighty":-3.268572,"marketCap":75570923},{"date":"2024-05-24","current":-2.288752,"twenty":-16.555414,"median":-7.880326,"eighty":-3.257706,"marketCap":68553623},{"date":"2024-05-31","current":-2.180622,"twenty":-16.555414,"median":-7.880326,"eighty":-3.236893,"marketCap":65314869},{"date":"2024-06-07","current":-2.314496,"twenty":-16.555414,"median":-7.880326,"eighty":-3.221739,"marketCap":69324719},{"date":"2024-06-14","current":-2.332578,"twenty":-16.555414,"median":-7.8854,"eighty":-3.215662,"marketCap":69866318},{"date":"2024-06-21","current":-2.224086,"twenty":-16.555414,"median":-7.793671,"eighty":-3.181352,"marketCap":66616722},{"date":"2024-06-28","current":-2.133676,"twenty":-16.56918,"median":-7.730784,"eighty":-3.173129,"marketCap":63908725},{"date":"2024-07-05","current":-1.98902,"twenty":-16.56918,"median":-7.646826,"eighty":-3.154082,"marketCap":59575930},{"date":"2024-07-12","current":-2.242168,"twenty":-16.56918,"median":-7.50542,"eighty":-3.134102,"marketCap":67158321},{"date":"2024-07-15","current":-2.314496,"twenty":-16.56918,"median":-7.491698,"eighty":-3.128727,"marketCap":69324719},{"date":"2024-08-02","current":-2.688567,"twenty":-16.607352,"median":-7.295099,"eighty":-3.110886,"marketCap":80529027},{"date":"2024-08-09","current":-2.323015,"twenty":-16.607352,"median":-7.150096,"eighty":-3.099278,"marketCap":69579874},{"date":"2024-08-16","current":-2.27142,"twenty":-16.607352,"median":-6.843832,"eighty":-3.09443,"marketCap":66100881},{"date":"2024-08-23","current":-2.345527,"twenty":-16.607352,"median":-6.688854,"eighty":-3.070128,"marketCap":68257484},{"date":"2024-08-30","current":-2.292699,"twenty":-16.607352,"median":-6.596464,"eighty":-3.04486,"marketCap":66720153},{"date":"2024-09-06","current":-2.303265,"twenty":-16.607352,"median":-6.46689,"eighty":-3.041239,"marketCap":67027619},{"date":"2024-09-13","current":-2.535705,"twenty":-16.607352,"median":-6.274951,"eighty":-3.024892,"marketCap":73791874},{"date":"2024-09-20","current":-2.324396,"twenty":-16.607352,"median":-6.057367,"eighty":-2.994322,"marketCap":67642551},{"date":"2024-09-27","current":-2.218741,"twenty":-16.607352,"median":-5.699353,"eighty":-2.972739,"marketCap":64567890},{"date":"2024-10-04","current":-2.303265,"twenty":-16.607352,"median":-5.568012,"eighty":-2.95642,"marketCap":67027619},{"date":"2024-10-11","current":-2.134218,"twenty":-16.607352,"median":-5.39486,"eighty":-2.919808,"marketCap":62108161},{"date":"2024-10-18","current":-2.007433,"twenty":-16.607352,"median":-5.332349,"eighty":-2.918118,"marketCap":58418567},{"date":"2024-10-25","current":-1.91171,"twenty":-16.607352,"median":-5.243092,"eighty":-2.890338,"marketCap":55632924},{"date":"2024-10-31","current":-1.897341,"twenty":-16.607352,"median":-5.044113,"eighty":-2.883743,"marketCap":55214770},{"date":"2024-11-08","current":-1.478527,"twenty":-16.609949,"median":-4.981516,"eighty":-2.848594,"marketCap":43026812},{"date":"2024-11-15","current":-1.18354,"twenty":-16.609949,"median":-4.934298,"eighty":-2.836112,"marketCap":34442357},{"date":"2024-11-22","current":-1.277361,"twenty":-16.609949,"median":-4.898885,"eighty":-2.816927,"marketCap":37172656},{"date":"2024-11-29","current":-1.391679,"twenty":-16.609949,"median":-4.828057,"eighty":-2.773442,"marketCap":40499440},{"date":"2024-12-06","current":-1.228732,"twenty":-16.609949,"median":-4.756274,"eighty":-2.752046,"marketCap":35757501},{"date":"2024-12-13","current":-1.616384,"twenty":-16.609949,"median":-4.688829,"eighty":-2.728223,"marketCap":47038597},{"date":"2024-12-20","current":-1.677557,"twenty":-16.609949,"median":-4.668862,"eighty":-2.705881,"marketCap":48818815},{"date":"2024-12-27","current":-1.545563,"twenty":-16.609949,"median":-4.632739,"eighty":-2.704326,"marketCap":44977627},{"date":"2025-01-03","current":-0.909709,"twenty":-16.609949,"median":-4.608851,"eighty":-2.687028,"marketCap":26473567},{"date":"2025-01-10","current":-0.803368,"twenty":-16.612546,"median":-4.588407,"eighty":-2.645781,"marketCap":23378922},{"date":"2025-01-17","current":-1.07211,"twenty":-16.612546,"median":-4.535819,"eighty":-2.62505,"marketCap":29568709},{"date":"2025-01-24","current":-1.05142,"twenty":-16.56918,"median":-4.511084,"eighty":-2.607666,"marketCap":28998085},{"date":"2025-01-31","current":-1.073453,"twenty":-16.521638,"median":-4.464712,"eighty":-2.573626,"marketCap":29605762},{"date":"2025-02-07","current":-1.056257,"twenty":-16.393722,"median":-4.436345,"eighty":-2.54602,"marketCap":29131477},{"date":"2025-02-14","current":-1.088501,"twenty":-16.278983,"median":-4.396899,"eighty":-2.522118,"marketCap":30020762},{"date":"2025-02-21","current":-1.168806,"twenty":-16.266724,"median":-4.365891,"eighty":-2.492369,"marketCap":32660481},{"date":"2025-02-28","current":-0.910729,"twenty":-16.242394,"median":-4.296201,"eighty":-2.463292,"marketCap":25448923},{"date":"2025-03-07","current":-0.94361,"twenty":-16.23404,"median":-4.238424,"eighty":-2.421882,"marketCap":26367741},{"date":"2025-03-14","current":-0.834467,"twenty":-16.223526,"median":-4.180842,"eighty":-2.404906,"marketCap":23317885},{"date":"2025-03-21","current":-0.750191,"twenty":-16.223526,"median":-4.154019,"eighty":-2.366658,"marketCap":20962933},{"date":"2025-03-28","current":-0.660113,"twenty":-16.210733,"median":-4.131589,"eighty":-2.354732,"marketCap":18445837},{"date":"2025-04-04","current":-0.549587,"twenty":-16.210733,"median":-4.10798,"eighty":-2.345527,"marketCap":15357375},{"date":"2025-04-07","current":-0.597113,"twenty":-16.210733,"median":-4.10798,"eighty":-2.343901,"marketCap":16685414}],"updateTime":1744134177298}}}